ApprovalTrail

Approval · Notice of Compliance 17409 · 2015

FINASTERIDE: Notice of Compliance 17409

Issued October 21, 2015

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
17409
Date
October 21, 2015
Company
Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Admin
Reason
Licensing agreement between two companies
Canadian reference product
PROPECIA (Merck Canada Inc)

Products in this notice

BrandDINStatus today
FINASTERIDE02447568Marketed

Medicinal ingredients